Company Filing History:
Years Active: 2010-2012
Title: Mostafa Mohamed: Innovator in Infection Treatment
Introduction
Mostafa Mohamed is a prominent inventor based in Heliopolis, Cairo, Egypt. He has made significant contributions to the field of medical science, particularly in the treatment of infections. With two patents to his name, his work focuses on innovative methods that enhance patient care and treatment outcomes.
Latest Patents
Mostafa's latest patents include groundbreaking methods for using sIP-10, CD26 inhibitors, and CXCR3 levels in samples to assess the clearance of infections and responses to interferon therapy. One of his inventions relates to the treatment of infections using CD26 (DPIV) inhibitors. This invention also encompasses an antibody that binds to the IP-10 protein, along with a method for monitoring the necessity of administering a CD26 inhibitor to patients. This method involves evaluating levels of sIP-10, CD26 activity, and CXCR3 cell levels in samples. Another patent focuses on using sIP-10 to assess HCV clearance and predict clinical outcomes in patients by measuring sIP-10 protein expression levels.
Career Highlights
Mostafa Mohamed is associated with the Institut Pasteur, where he continues to advance his research and innovations. His work is pivotal in developing new therapeutic strategies for chronic infections, showcasing his commitment to improving healthcare.
Collaborations
Mostafa collaborates with esteemed colleagues, including Matthew Albert and Jeremie Decalf, to further enhance the impact of his research and inventions.
Conclusion
Mostafa Mohamed's contributions to the field of infection treatment through his innovative patents highlight his dedication to advancing medical science. His work not only addresses current challenges in healthcare but also paves the way for future advancements in treatment methodologies.